List of All Articles with Tag 'al'

Don and Gail Patterson died days after a beef Wellington lunch cooked by their former daughter-in-law.

Hong Kong is making preparations for a possible direct hit by Super Typhoon Saola, which is shaping up

A Domino’s delivery driver has faced backlash after scolding a customer for not picking up their order from the store. Food delivery services are commonplace, especially in major towns and cities, and offer a convenient way for people to order food without having to leave their houses. But, one woman found she was being judged by the delivery driver for getting her food delivered a short distance. The incident was caught on a person’s doorbell camera when customer Ercina Rodriguez unexpectedly got into an argument with the person delivering her Domino’s order. In the clip, Rodriguez was asked by the person delivering her order: “You know the Domino’s is right there, right?” In an inaudible part of the clip, Rodriguez appeared to give her reasoning for why she opted for delivery, to which the delivery person replied, “Ok, that’s fair. That’s fair”. @erica.bk11 #fyp #dominos #viral Rodriguez then calmly responded: “I don’t see why I should have to explain myself to you about why I’m doing a delivery. They pay you for that, right? And you get a tip. What more do you want?” The driver shrugged their shoulders and said, “I’m just wondering”, to which Rodriguez replied, “It’s none of your business”. The TikTok has been viewed almost 700,000 times and people have been giving Rodriguez their support. One person commented: “So you paid the fee for delivery and tipped and this person asked why? I keep getting amazed every day.” “Love the way you handled that. People need to mind their own business,” another wrote. Another questioned: “Why is delivery an option then.” Someone else suggested: “I would’ve taken the tip back and called the store.” Sign up to our free Indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.

Liverpool continue to hunt reinforcements as they bid to put a difficult season last campaign behind them. Jurgen Klopp’s club entered the transfer window with a clear emphasis on bolstering their midfield, particularly considering the confirmed departures of James Milner, Fabio Carvalho, and Alex Oxlade-Chamberlain, as well as the exit of Jordan Henderson. The club has been proactive in pursuing this objective, and still may not be done yet in the market. Meanwhile, one of Jurgen Klopp’s stars has been linked with a mega-money transfer to Saudi Arabia, with both Henderson and Fabinho already having moved to the Middle East. LIVE: Follow all the latest transfer moves as deadline day approaches Here are the latest news and transfer updates around Anfield: Mohamed Salah Mohamed Salah has emerged as a target for Saudi Arabian champions Al Ittihad as the Middle Eastern league continues to flex its financial muscles after significant backing from the country’s Public Investment Fund. The Saudi Pro League have already bought Fabinho, Roberto Firmino and Jordan Henderson from the Merseyside club this summer but are now said to have turned their attention to Jurgen Klopp’s star forward, who only signed a new contract at the start of last season. The Daily Mail have reported that the Saudi club are willing to pay as much as £118 million for the 31-year-old but, despite that, Liverpool’s stance remains clear. The player is not for sale under any conditions and especially this late in the window. Ryan Gravenberch Versatile midfielder Ryan Gravenberch has been once again linked with Liverpool late in the window, with the Anfield club reigniting their interest in the Dutchman after missing out on other midfield targets, including Moises Caicedo and Romeo Lavia. According to Sky Sports Germany’s Florian Plettenberg, the Dutch midfielder is keen to leave the German club having started just three games last season. Negotiations remain ongoing between the two clubs with the defending Bundesliga champions said to want around €30m for the 21-year-old who joined from Ajax last summer. Cheick Doucoure Should a deal for Gravenberch fail to materialise, Liverpool may turn their attention back to Crystal Palace’s Cheick Doucoure, with the central midfielder attracting long-standing interest from the club. According to The Indeependent’s Miguel Delaney, Klopp’s side remain interested in the 23-year-old, although they have so far been put off by Palace’s asking price - believed to be around £70m. Read More Jurgen Klopp wanted a midfield change at Liverpool – instead he got a revolution New signing Wataru Endo compared to ‘one of the biggest Liverpool legends’ by Jurgen Klopp Jurgen Klopp makes definitive statement on Mohamed Salah transfer saga Transfers latest LIVE: Premier League updates ahead of deadline day Rumours: Salah bid well over £100m; Chelsea winger set for exit Liverpool hold talks with Bayern Munich over deal for Ryan Gravenberch

Like Wolfgang Wolf managing Wolfsburg or Arsene Wenger taking charge of Arsenal, perhaps Romelu Lukaku’s imminent arrival in Rome is striking a blow for nominative determinism in football. When Roma secure his services on a year’s loan, it may seem a triumph for the Giallorossi’s negotiating skills and an extension to the strange on-off relationship between Lukaku and Jose Mourinho. Yet for Lukaku and Chelsea, trapped in a loveless marriage during which neither has been able to formalise a lasting parting of the ways, it represents a failure on both fronts. Even as Chelsea have sold a host of players this summer, it is ever likelier that they will not recoup a transfer fee for a man who cost them a then club record £97m. Chelsea, it feels, have been doubly culpable in the last two summers, first being too generous and too willing to loan him out to Inter for a relatively small sum last year and then overpricing him 12 months on, when cash-strapped Italian clubs were unlikely to pay £40m and Lukaku had little interest in moving to Saudi Arabia. It was a sign he still has footballing ambitions. The wrong ones, perhaps. Lukaku’s flirtation with Juventus cost him a chance of a return to Inter; he has often had the feel of an outsider everywhere he has been but there was a sense of belonging among the Nerazzurri as a catalyst in their first Scudetto in 11 years. A willingness to join their enemies led Javier Zanetti, whose loyalty to Inter was established over 858 appearances, to accuse him of betrayal. So Roma it is, as the short-term replacement for Tammy Abraham, whose cruciate ligament injury will sideline him for much of the season. The odd, interconnected history of the supposed new Didier Drogbas continues: neither Lukaku nor Abraham has actually assumed the Ivorian’s totemic role at Stamford Bridge, the destiny that seemed to await each when he debuted at 18. When Lukaku makes his Roma bow, they will have played for a combined total of seven other clubs on loan when owned by Chelsea. Each has missed a decisive penalty in a Super Cup; Lukaku at least scored in a Club World Cup final but Abraham, with 18 goals in a breakthrough season under Frank Lampard, has arguably had the better Chelsea career. Tellingly, Mauricio Pochettino seemed to have little interest in resurrecting Lukaku’s. Meanwhile, he appears to be a curiously unfulfilled figure. A move to Mourinho’s United was supposed to be the end to his days as a wanderer, rendering him an iconic figure for an elite club. So, four years later, was his return to Chelsea. And, had he gone back to Inter this year, that could have been his mantle. Instead, he is forever a staple of transfer market discussion. And a player with a remarkable 355 goals by the age of 30 – 280 in club football, 75 for his country – now feels defined by those he didn’t score: the four misses in 45 minutes by a semi-fit Lukaku as Croatia held on for a stalemate that brought Belgium’s Golden Generation to an undignified end, the late header that Ederson somehow saved in the Champions League final. It may be harsh or recency bias: time can supply more context. For now, however, Lukaku can be portrayed as a nearly man, a player who has lost more finals than he has won, one who has a solitary league title since leaving Anderlecht as a teenager, who, like Zlatan Ibrahimovic – another sizeable Mourinho striker – is among the most prolific forwards never to win the Champions League. Strikers can require a selfish streak but Lukaku may end up defined by individual exploits: he could join Cristiano Ronaldo, Ali Daei and Lionel Messi in the select group who score a century of international goals. At club level, meanwhile, Chelsea may deem him Thomas Tuchel’s folly, the most damaging part of their Champions League-winning manager’s legacy, his huge salary making him the hardest player to shift. For Roma, where the wider perception of Mourinho is a manager in decline, raging against the brightest of lights dying out, Lukaku might be a boost to the ego. Lukaku spent some of an injury-hit affected 2022-23 on the bench but in his previous campaign in Serie A, two years earlier, he was the division’s best player. In his first spell at Inter, he delivered 23 and 24 league goals in two seasons, adding 11 assists in the second. Even last year, he was directly involved in a goal every 100 minutes in Serie A. For Roma, whose tally of 50 Serie A goals was both meagre and their lowest in 26 years, he shapes up as their ideal acquisition. For them, Lukaku could be forgiven for a few big-game misses in exchange for a consistent return in lesser matches. There is something poignant in Mourinho bringing together another band of thirty-somethings, chasing figures from his past as he bids to recreate it. The previous times he and Lukaku linked up, it was with more of a promise of greatness and, while the Belgian scored 25 goals in their first year together at Old Trafford, their finest exploits came without the other. For now, though, Lukaku is a coup for Mourinho and Roma offer an escape from Chelsea for him. Read More Romelu Lukaku, a chessboard and the Jose Mourinho phone call that lured him to Roma Chelsea transfer news: Brennan Johnson, Romelu Lukaku, Trevoh Chalobah and more The answers to Miguel Delaney’s Reading the Game newsletter quiz Chelsea’s Academy stars can rise to Carabao Cup challenge – Mauricio Pochettino Romelu Lukaku, a chessboard and the Jose Mourinho phone call that lured him to Roma Roma set to sign Chelsea striker Romelu Lukaku on season-long loan

HONG KONG Hong Kong's July retail sales rose 16.5% from a year earlier in the eighth consecutive month

A mum who was told she likely suffered from carpal tunnel syndrome after feeling numbness in her right hand during her pregnancy has been given just a few years to live after scans revealed she will soon be paralysed. Charlotte Parker, 28, from West Berkshire, was diagnosed with amyotrophic lateral sclerosis (ALS) nine months after giving birth and is now trying to create “happy memories” with her young family while there is still time. The rare condition, a type of motor neurone disease (MND), means Charlotte only has two to five years’ life expectancy during which time she will become increasingly paralysed. Charlotte, who lives in Thatcham with her fiance George, 32, a mechanic, and their three children, says she wants her 11-month-old son Jimmy to know she was there. Her friends and family are fundraising so she can afford to take her family to Disneyland in Paris and take advantage of what time they have left together. “I don’t think you can imagine having to tell your parents at 28 that you have been diagnosed with a terminal illness,” Charlotte, who works as a revenue and debt accountant at an energy company, told PA Real Life. “At the moment my life is so fast paced that I don’t really have much time to slow down and think about what’s happening. “Most people think MND-ALS affects older people but it actually affects a wide range of people. It can happen to anyone.” Charlotte was seven months’ pregnant when she began feeling a strange “numbness and weakness” in her right hand. “I was struggling to open jars and bottles,” she said. “Gradually it just got worse and worse and by the time I gave birth to Jimmy, I was considerably weaker. “Doing day-to-day tasks while trying to learn how to look after a newborn baby was definitely a challenge.” After flagging the numbness to her midwife, Charlotte was told she likely suffered from carpal tunnel syndrome, a common health condition caused by pressure on a nerve in the wrist. But Charlotte was referred to a neurologist when she went for a routine checkup six weeks after Jimmy was born. “He sent me for an MRI in January for possible inflammation in the brain,” she said. “I think subconsciously at the time that’s when I knew it was something a bit more serious.” While Charlotte was worried, her results came back and suggested there was no problem with her brain or spinal cord. Instead of getting better, however, the numbness started to spread to her other hand. “I kept calling because it started going into my left hand as well,” she said. “I am still able to move my fingers in my left hand but my right hand does not really work anymore.” In June, Charlotte was given an electromyography, a medical test which looks at how a person’s nerves and muscles respond to stimulation. “They put stickers on you and send pulses up your arm,” she said. “I got called in to see the neurologist quite quickly after that, which is when he advised that he strongly believed that it was MND-ALS.” I want to do as many days out with the children as possible so that we have those memories all together. Charlotte Parker ALS, the most common motor neurone disease, is incurable and causes progressive weakness and paralysis, usually leading to death within three to five years, the National Institute of Neurological Disorders and Stroke said. Charlotte’s worst fears were confirmed after she visited John Radcliffe Hospital in Oxford in July and was formally diagnosed. “It’s been a lot to adjust to, especially with a four(-year-old), seven(-year old) and eleven-month-old,” she said. “To know that there is no cure or treatment that will give me a substantial lease of life. “It is just going to deteriorate pretty quickly.” Charlotte broke the devastating news to her family and friends that her illness is terminal. “My youngest is completely none the wiser and the girls are aware that my hands are getting weaker and that it will move to my legs, but we haven’t gone into the detail of what it means will happen.” Unfortunately, doctors are unable to say how quickly Charlotte’s condition is progressing. “Each person’s story is different,” she said. “It’s such a maze on how one person’s body deteriorates to the next.” But Charlotte is not letting the diagnosis get in the way of her family plans. The mum, who does not have life insurance, plans on continuing to work for “as long as possible”. “I am fortunate that my work provides death in service,” she said. “If I can, I will try and work for as long as possible so that my partner and children do have something to help them for the next however many years.” She also plans on marrying the “love of her life”, George, after getting engaged two years ago and falling pregnant. “I fell pregnant and it just got pushed to the side. I didn’t want to get married nine months’ pregnant,” she said. “It’s time for us to celebrate us as a couple rather than just accepting that we’re not going to be together for the rest of our lives. “We have to make good of what we can and celebrate what we do have, right now, rather than just accepting the situation.” The couple, who recently went on holiday to Pembrokeshire, are also looking to create “happy memories” while there is still time. “We were on the beach late evening, when it was raining and full of wind, and we were taking photos running in and out of the sea to make memories,” she said. “I want to do as many days out with the children as possible so that we have those memories all together. “Even silly things, like being there for Jimmy’s first haircut and taking him to feed the ducks so that we can capture those memories and that he knows that I was there.” Charlotte’s friends have set up a fundraiser on GoFundMe to help them cover their costs, including a trip to Disneyland, Paris. “It would be a great trip to have with them,” she said. “I just want to enjoy my family and do as much as I can with them because there will come a point where even though I’m around, it will be a lot more complicated.” They have so far raised £11,235 of their £15,000 target. Charlotte continued: “A huge thank you to anyone who can help and it will go to creating some of the best memories I can with my family before the inevitable does happen.” To support Charlotte, visit: www.gofundme.com/f/complete-her-wishes-with-her-family Read More Woman’s blood cancer misdiagnosed as carpal tunnel due to burning hand pain What happens to your brain when you’re pregnant? Cyclist completes 960-mile ride to remember friends who died from MND What is sickle cell disease and how do you know if you have it? Project launched to bust myth that cancer is a ‘white person’s disease’ Man who lengthened his limbs by three inches says he feels ‘so much happier’

The Swiss bank reports bumper profits following the rescue of its rival but staff face redundancies.

Agnetha Fältskog of legendary Swedish pop group ABBA has relaunched her solo career with a new single.

Portugal midfielder Matheus Nunes has been given permission to travel to Manchester City for a medical after Wolves agreed a club-record £53million deal. After overcoming some minor sticking points in final negotiations over an initial £47.3m deal late on Wednesday night, both clubs were able to come to an agreement which involved a bigger fee. The PA news agency understands there are no add-ons included but there is a 10 per cent sell on fee on any profit City make on the 25-year-old. Nunes became Wolves’ record signing when he joined from Sporting Lisbon for an initial £38m last summer on a five-year contract with the option of a further 12 months. He made 34 appearances last term, scoring one goal and proving one assist. However, on learning of City’s interest Nunes absented himself from training in an attempt to force through a move. In a separate deal, City’s 21-year-old midfielder Tommy Doyle is set to undergo a medical for a season-long loan at Molineux, with Wolves having a £4.2m option to buy and City retaining a 50 per cent sell-on fee on any profit made on the player. The England Under-21 international is the grandson of Manchester City greats Mike Doyle and Glyn Pardoe and impressed on loan at Sheffield United last season, scoring four goals and providing seven assists in 38 appearances as he helped the Blades earn promotion to the Premier League. Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live

Gary Oldman has landed a part in Paolo Sorrentino's new film which is described as a love letter to his home city of Naples.

More must be done to get black, Asian and ethnic minority people to participate in breast cancer trials, experts have said, as they warned that people from these backgrounds have been under-represented in previous studies. Medics said that they want research into the disease to be “relevant to people we see in the clinic”. Experts said that there is a “broad misperception” that black women “don’t suffer as much from breast cancer” which can result in the perception that “cancer is a white person’s disease”. If I hadn’t gone on the trial at The Christie, I wouldn’t be here today Jasmin David This is despite the fact that previous studies have found that black women are more likely to die from breast cancer compared to their white peers. They are also more likely to develop more aggressive cancer and be diagnosed when their cancer is at a more advanced stage. It comes as the NHS Race and Health Observatory launched a new campaign alongside Macmillan Cancer Support to improve diversity in breast cancer clinical trials. The project, which is being supported by Roche, aims to raise awareness of the lack of diversity in clinical studies, improve communications and provide longer term support to patients. Specialist nurses will be provided at two major cancer hubs – Bart’s Health NHS Trust in London and The Christie NHS Foundation Trust in Manchester – to help guide patients through the process. Men, who account for 1% of breast cancer patients in the UK, are also being included. The NHS Race and Health Observatory said that there are “multiple barriers” around the recruitment, communication and retention of black, Asian and ethnic minority patients in clinical trials. It said that data show that people from an ethnic minority background are poorly under-represented in many clinical trials. And the Caribbean African Health Network said that there has been a “disengagement” in research “as a result of mistrust”. Jasmin David, a 53-year-old breast cancer patient from Fallowfield in south Manchester, took part in a clinical trial which saved her life and is encouraging others to do the same. Two years after her initial diagnosis and treatment at The Christie she was told that the cancer had come back and had spread to her lungs, lymph nodes and chest bone. The mother-of-two was told she had less than a year to live but was also offered the opportunity to take part in a clinical trial at the National Institute for Health and Care Research Manchester Clinical Research Facility. Ms David is now cancer-free. “If I hadn’t gone on the trial at The Christie, I wouldn’t be here today,” she said. “I have two children and now I get to be there for them as they grow up. “Research gave me a second chance and life and I’m relishing every second of it. “I want everyone, no matter their ethnicity, to have equal access to clinical trials, so I’m glad that this important piece of work is being done. I hope that by sharing my story I can inspire more women like me to come forward and take part in clinical trials.” Dr Habib Naqvi, chief executive of the NHS Race and Health Observatory, said: “We are pleased to announce this partnership and our joint commitment to ensuring inclusion and representation in future breast cancer trials. “We believe that when targeted, culturally sensitive interventions and communications are put in place, under-represented groups can be successfully recruited into clinical trials.” He added: “There is a broad misperception that black women don’t suffer as much from breast cancer or it does not run in their family history. This can result in the perception that cancer is a white person’s disease. “We want this pilot to encourage women at risk, those already diagnosed and individuals undergoing post treatment to come forward and share their experiences and get the information needed.” Professor Richard Simcock, chief medical officer at Macmillan Cancer Support, added: “As a Breast Cancer Oncologist I want to know that research is relevant to the people we see in clinic. Historically that has not been the case. “I’m delighted that Macmillan can support this project to ensure that future evidence from clinical trials is representative and inclusive.” Charles Kwaku-Odoi, chief executive of the Caribbean African Health Network, said: “Across the black community there is an undoubted legacy of disengagement in research and most certainly clinical trials that stems back decades as a result of mistrust. “This has not served us well because it leads to a lack of appropriate interventions that perpetuate the grave health inequalities in breast cancer care. “This partnership approach to build solutions to improve engagement in clinical trials in breast cancer treatment and care is very much welcomed. We are looking forward to working in a collaborative way to build trust, improve awareness and ensure that barriers surrounding access to clinical trials are addressed.” Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live 10 slick ways to kit out your student digs 4 essential officecore trends to update your work wardrobe Sickle Cell Awareness Month: What is sickle cell disease and how do you know if you have it?